Combination Vaccines and the ‘One-Shot’ Idea: What Exists, What’s in Development, and What the Evidence Shows

Headlines have announced that scientists are working on a “super vaccine” that would deliver all childhood immunizations in a single shot. The idea is appealing to parents who dislike multiple injections and to health workers in places where returning for follow-up doses is difficult. Some versions of the story have also raised fears that combining many vaccines could overwhelm a child’s immune system.

The reality is more incremental. Combination vaccines that protect against several diseases in one injection have been used for decades, and newer ones reduce the number of shots further. Researchers are also developing technologies that could deliver multiple doses from a single injection over time. But no vaccine replaces the full childhood schedule with one shot. This article explains what combination vaccines exist, how they are tested, what research on single-injection technologies has shown, and what the evidence says about immune system concerns.

Is there a vaccine that gives all childhood immunizations in one shot? No single shot covers everything, but combination vaccines already bundle several at once, like MMR (measles, mumps, rubella) and DTaP (diphtheria, tetanus, pertussis). These are rigorously tested and reduce the number of injections children need. Combining vaccines does not overwhelm the immune system, which handles far more antigens daily. Researchers continue developing new ways to deliver more protection in fewer shots.

What Combination Vaccines Are Already Used?

Combination vaccines already protect against several diseases in one shot, such as MMR (measles, mumps, rubella), DTaP (diphtheria, tetanus, pertussis), and others that bundle multiple vaccines to reduce injections. Combination vaccines are not new. The DTP vaccine, protecting against diphtheria, tetanus, and pertussis, has been used since the 1940s, and the MMR vaccine against measles, mumps, and rubella since 1971. Over time, manufacturers have combined more antigens into single products to reduce the number of injections. Examples include vaccines that combine DTaP with inactivated polio vaccine, with or without Haemophilus influenzae type b (Hib) and hepatitis B vaccines, and the MMRV vaccine, which adds varicella (chickenpox) to MMR.

A 2020 report in the CDC’s Morbidity and Mortality Weekly Report by Sarah Oliver and Kelly Moore described the licensure and Advisory Committee on Immunization Practices recommendations for a hexavalent vaccine combining DTaP, inactivated poliovirus, Hib, and hepatitis B, licensed by the FDA in December 2018 for infants at 2, 4, and 6 months. Using a hexavalent vaccine can reduce the number of injections at infant visits while providing the same protection.

How Are Combination Vaccines Tested for Safety?

Combination vaccines undergo rigorous clinical trials to confirm they are safe and that each component works effectively when given together, meeting the same standards as individual vaccines before approval. Combining vaccines is not as simple as mixing them. Components can interact, sometimes reducing the immune response to one antigen or increasing side effects. Before approval, manufacturers must show in clinical trials that the combination produces immune responses to each component that are not inferior to those from separately administered vaccines, and that safety is acceptable compared with separate injections. Regulators review these data, and safety monitoring continues after approval.

Combination vaccines sometimes involve trade-offs. For example, the MMRV vaccine is associated with a somewhat higher risk of fever-related seizures after the first dose in young children than separate MMR and varicella vaccines given at the same visit, which is why U.S. recommendations generally favor separate vaccines for the first dose unless parents prefer the combination. Such trade-offs are identified through careful studies and reflected in recommendations.

Could There Be One Shot for All Childhood Vaccines?

Researchers are exploring technologies, like single-injection systems that release doses over time, to deliver more protection in fewer shots, though a single shot covering every childhood vaccine does not yet exist. Many vaccines require several doses spaced weeks or months apart to build strong, lasting immunity. In places where families travel long distances to clinics, missed follow-up doses are a major reason children remain unprotected. Researchers have therefore sought ways to deliver a full series in one injection.

A 2017 study in Science by Kevin McHugh and colleagues at the Massachusetts Institute of Technology described a fabrication method for tiny, fillable polymer microparticles that can be loaded with drugs or vaccines and sealed so that they release their contents in pulses at preset times after injection, potentially allowing a single shot to deliver an initial dose and later boosters. Experiments in animals showed that particles could release contents at different times. Turning such technologies into approved vaccines requires solving challenges such as keeping vaccines stable inside particles at body temperature for weeks or months, and proving safety and effectiveness in people.

Other approaches include combining more antigens into single formulations, developing vaccines that require fewer doses, and new platforms such as messenger RNA, which some companies have used to develop combined vaccines against more than one respiratory virus, such as influenza and COVID-19, tested in clinical trials.

Does Combining Vaccines Overwhelm a Child’s Immune System?

No. A child’s immune system responds to countless antigens every day from the environment, so the antigens in vaccines, even combined, are a tiny addition that does not overwhelm immunity. A common concern is that giving many vaccines at once, or combining them, might overload a child’s immune system. A 2002 analysis in Pediatrics by Paul Offit and colleagues addressed this question by estimating the immune system’s capacity and the antigens in vaccines. The authors concluded that infants have an enormous capacity to respond to antigens, that vaccines represent a tiny fraction of the antigens children encounter daily from the environment, food, and microbes in their bodies, and that the evidence does not support the idea that multiple vaccines weaken or overwhelm the immune system. They also noted that the number of antigens in the vaccine schedule has decreased over time as vaccines became more purified, even as protection was added against more diseases.

Studies comparing children who received vaccines on the recommended schedule with those who received them later or separately have not shown benefits of spacing out vaccines, while delays leave children unprotected longer. Combination vaccines are tested to ensure each component works and side effects remain acceptable.

Concern	What the evidence shows
Too many antigens at once	Vaccines are a small fraction of daily antigen exposure; immune capacity is vast
Combinations work less well	Approval requires showing each component works as well as separate vaccines
More side effects	Generally comparable; some combinations carry specific trade-offs, reflected in recommendations
One shot for everything soon	No single vaccine replaces the schedule; single-injection technologies remain in development

Do Today’s Vaccines Contain More Antigens Than Before?

Despite more vaccines on the schedule, today’s vaccines contain far fewer antigens overall than those of past decades, because modern vaccines are more refined and use purified components. Parents are sometimes surprised to learn that, although children today are protected against more diseases than in past decades, the number of immune-stimulating components in vaccines has declined. Older vaccines, such as the whole-cell pertussis vaccine and the smallpox vaccine, contained thousands of proteins. Modern vaccines are more purified and often contain only a few specific proteins or sugars. The Offit analysis estimated that the total number of antigens in the U.S. childhood schedule decreased substantially between 1980 and 2000, even as new vaccines were added, a trend that has continued with newer purified and conjugate vaccines.

Combination Vaccines Around the World

Combination vaccines are especially important globally. A pentavalent vaccine protecting against diphtheria, tetanus, pertussis, hepatitis B, and Hib has been used in many low- and middle-income countries with support from Gavi, the Vaccine Alliance, allowing millions of children to receive protection against five diseases with fewer injections and lower delivery costs. Hexavalent vaccines that also include polio are widely used in Europe and increasingly elsewhere. These programs have contributed to large declines in childhood deaths from vaccine-preventable diseases.

New Delivery Methods

Beyond combinations, researchers are developing needle-free delivery methods. Microneedle patches, which deliver vaccines through tiny dissolving needles in a patch applied to the skin, are being tested for measles-rubella and other vaccines and could be applied without trained health workers and stored more easily. Oral and nasal vaccines exist for some diseases, such as oral polio and rotavirus vaccines and a nasal influenza vaccine. These approaches aim to make vaccination easier, less painful, and more accessible, complementing efforts to reduce the number of injections.

Why Fewer Shots Matter

Reducing the number of injections has practical benefits. Fewer shots mean less pain and distress for children and parents, shorter clinic visits, and potentially higher vaccination coverage, since some parents delay vaccines partly because of the number of injections. In low-resource settings, combination and single-dose vaccines reduce costs for storage, transport, and staff time, and help children complete their protection even if they cannot return for later visits. These benefits explain why public health organizations encourage development of combination and longer-lasting vaccines.

Safety Monitoring After Approval

Once combination vaccines are in use, safety monitoring continues through systems such as the Vaccine Adverse Event Reporting System and the Vaccine Safety Datalink in the United States, which can detect rare side effects that clinical trials might miss. This monitoring identified, for example, the increased fever-related seizure risk with MMRV in young children, leading to adjusted recommendations. Our article on vaccine safety research and the CDC whistleblower controversy explains how these systems work and how large studies address safety questions. Pets face similar questions about boosters and timing, covered in our guide to how often pets should be vaccinated.

Questions Parents Can Ask

Which vaccines will my child receive at this visit, and are any of them combination vaccines? What side effects are common, and what should I watch for? Are there differences between combination and separate options for my child? What happens if we delay a vaccine? Pediatricians can explain the reasons behind the recommended schedule and help parents make informed decisions.

How the Schedule Is Designed

The childhood immunization schedule is designed to protect children at the ages when they are most vulnerable to specific diseases and when vaccines work best. Some vaccines are given in infancy because diseases such as pertussis, Hib, and pneumococcal infection are most dangerous to young babies. Others, such as MMR, are given after the first birthday, when maternal antibodies that can interfere with the vaccine have waned. Multiple doses are often needed because the infant immune system develops stronger, longer-lasting protection after repeated exposures. Combination vaccines are designed to fit into this schedule without changing its timing. A single injection containing every vaccine would not work for this reason: different vaccines are needed at different ages.

Managing Pain and Anxiety at Vaccine Visits

For parents worried about the number of shots, evidence-based strategies can reduce pain and distress. Breastfeeding or offering sweet solutions to infants during injections, holding children upright in a parent’s lap, using distraction such as toys or videos for older children, and applying topical numbing creams can help. Giving the most painful vaccine last and using combination vaccines to reduce the number of injections also help. Staying calm and positive affects children’s responses. Pediatric clinics can suggest approaches suited to each child’s age.

Common Misconceptions

“A super vaccine will soon replace all childhood shots.” No such vaccine exists or is close to approval; progress is incremental.

“Combination vaccines are untested mixtures.” Each combination undergoes clinical trials and regulatory review.

“Spacing out vaccines is safer.” Studies have not shown benefits, and delays leave children unprotected longer.

“More vaccines mean more antigens than ever.” Modern vaccines contain far fewer antigens than older ones.

Key Terms

Combination vaccine: A vaccine protecting against more than one disease in a single injection.

Antigen: A substance that triggers an immune response, such as a protein from a virus or bacterium.

Hexavalent: Protecting against six diseases.

Non-inferiority: A trial design showing a new product is not worse than an existing one by more than a set margin.

Pulsatile release: Delivery of a drug or vaccine in bursts at preset times.

The Bottom Line

A single shot that replaces all childhood vaccines remains a goal rather than a reality. Combination vaccines, including a hexavalent vaccine licensed in the U.S. in 2018, already reduce the number of injections while maintaining protection, and they undergo clinical trials and ongoing safety monitoring. Researchers are developing single-injection, timed-release technologies and needle-free delivery, which could help children in hard-to-reach areas complete their vaccinations. Evidence indicates that the recommended schedule, including combination vaccines, does not overwhelm children’s immune systems.

What Researchers Hope to Achieve

Vaccine developers have several goals for the future: fewer doses for long-lasting protection, vaccines that do not require refrigeration, delivery methods that do not need trained staff, and combinations that protect against more diseases at once. Achieving these goals could transform vaccination in places with limited health infrastructure. Progress depends on overcoming technical challenges, demonstrating safety and effectiveness in rigorous trials, and making products affordable. Each new combination or delivery method must meet the same standards that apply to existing vaccines before it can be used.

Vaccine Hesitancy and the “Too Many Too Soon” Concern

Concern about the number of vaccines, sometimes summarized as “too many too soon,” is one of the most common reasons parents give for delaying or spacing out vaccines. Health professionals have found that acknowledging this concern and explaining how the immune system handles antigens, why the schedule is timed as it is, and how combination vaccines reduce injections can help. Research suggests that alternative schedules that delay vaccines increase the time children are vulnerable without demonstrated benefits. The pursuit of fewer injections through combination vaccines is one way the medical community has responded to parents’ concerns while maintaining protection.

Regulatory Review of Combination Vaccines

In the United States, the FDA’s Center for Biologics Evaluation and Research reviews combination vaccines through the biologics license application process, examining clinical trial data on immune responses, safety, and manufacturing consistency. The CDC’s Advisory Committee on Immunization Practices then considers whether and how to recommend the vaccine, weighing evidence on effectiveness, safety, cost, and practical considerations. Other countries have similar processes, and the World Health Organization prequalifies vaccines for use by UN procurement agencies.

Key Facts at a Glance

Combination vaccines such as DTaP, MMR, MMRV, and a hexavalent vaccine against diphtheria, tetanus, pertussis, polio, Hib, and hepatitis B reduce the number of injections children need. The hexavalent vaccine was licensed in the U.S. in December 2018 and recommended for infants at 2, 4, and 6 months. MIT researchers described microparticles in 2017 designed to release vaccine doses at preset times after one injection, tested in animals. A 2002 analysis concluded that infants have a vast capacity to respond to antigens and that vaccines represent a small fraction of the antigens they encounter. No vaccine replaces the entire schedule with one shot.

For parents, the practical message is that combination vaccines can reduce the number of injections at a visit without reducing protection, and that pediatricians can explain which options fit each child.

Further Reading

The CDC publishes the recommended immunization schedule and information about each vaccine, including combination products. The FDA lists licensed vaccines and their prescribing information. The Children’s Hospital of Philadelphia Vaccine Education Center offers parent-friendly explanations of how vaccines work and how the schedule is developed. Research articles cited here provide the scientific basis for combination vaccine safety and development.

Lessons From the “Super Vaccine” Headlines

Headlines about a coming super vaccine illustrate how early research can be overstated. Laboratory and animal studies of new delivery technologies are important steps, but most experimental technologies take many years to reach people, and many never do. Readers can evaluate such headlines by asking whether the research involved people or animals, whether the technology has entered clinical trials, and what regulators have said. In the case of combination vaccines, the reality is steady progress: combinations covering more diseases have been developed over decades, and new technologies may further reduce injections in the future.

Understanding this history can reassure parents that each step toward fewer shots is grounded in careful testing, and that the goal is to keep the same strong protection with less discomfort and fewer visits.

Combination Vaccines for Adults

Combination vaccines are not only for children. Adults commonly receive Tdap, which protects against tetanus, diphtheria, and pertussis, and combined hepatitis A and B vaccines are available for adults at risk of both infections. Researchers are developing combination vaccines for adults against multiple respiratory viruses, such as influenza, COVID-19, and respiratory syncytial virus, which could simplify seasonal vaccination for older adults and people with chronic conditions. As with childhood combinations, these products must demonstrate that each component works and that safety is acceptable.

For older adults, who are recommended several vaccines, fewer injections and combined seasonal shots could improve uptake, an important consideration since respiratory infections cause many hospitalizations in this age group each year.

Global Equity and Single-Dose Goals

Single-dose and combination vaccines are particularly valuable for children in low-income countries, where reaching families for multiple visits is difficult and many children miss later doses. Global health organizations have prioritized research on vaccines that require fewer doses, remain stable without refrigeration, and can be delivered by community health workers. The World Health Organization has also reviewed evidence on reducing the number of doses for some vaccines, such as the human papillomavirus vaccine, where a single dose has been found to provide strong protection in studies, leading to updated recommendations in many countries. These advances illustrate how simplifying vaccination can expand protection worldwide.

What Happens After a Combination Vaccine

Common side effects after combination vaccines are similar to those after individual vaccines: soreness, redness, or swelling at the injection site, fussiness, mild fever, and sleepiness, usually lasting a day or two. Parents can comfort children, offer fluids, and ask their pediatrician about fever-reducing medicine if needed. Serious reactions are rare. Severe allergic reactions occur in roughly one to a few per million doses for most vaccines, and clinics observe patients briefly after vaccination and are equipped to respond. Parents should contact their doctor if a child has a high fever, unusual crying that lasts for hours, or other concerning symptoms.

Reporting side effects to the Vaccine Adverse Event Reporting System, which anyone can do, helps safety monitoring systems detect rare problems early.

How Combination Vaccines Are Manufactured

Producing combination vaccines is technically demanding. Each component, such as purified toxoids, inactivated viruses, or conjugated sugars, is manufactured separately under strict quality controls and then combined in precise amounts. Manufacturers must show that the components remain stable together over the product’s shelf life and that the combination does not degrade any component. Some combinations require mixing at the point of use, with one component supplied as a powder and another as a liquid. These complexities help explain why only a limited number of combinations exist and why new ones take years to develop and license.

Supply considerations also matter: when a combination vaccine is in short supply, clinicians can usually substitute the separate component vaccines to keep children on schedule.

A Balanced View

The appeal of a single vaccine for everything is understandable, but immunology and practical realities make that goal distant. In the meantime, combination vaccines deliver real benefits: fewer injections, simpler schedules, and protection against more diseases with less discomfort. Concerns about combining vaccines are reasonable questions that have been studied extensively, and the evidence supports the safety and effectiveness of approved combinations. New technologies for single-injection and needle-free delivery deserve attention, but they must pass the same rigorous testing before reaching children.

Summary for Parents

Your child’s vaccines may include combination products that protect against several diseases in one shot, reducing the number of injections at each visit. These vaccines are tested to ensure each component works and that side effects are acceptable, and they are monitored after approval. A single vaccine covering the entire schedule does not exist, but research on single-injection and needle-free technologies continues. If you have questions about the number or timing of vaccines, your pediatrician can explain the options, including which combination vaccines are available at your clinic and how they fit your child’s schedule.

Keeping a record of your child’s vaccinations, including which combination products were given, helps ensure that future doses are scheduled correctly and avoids unnecessary repeats.

Parents who encounter claims online about new or combined vaccines can bring them to their child’s doctor, who can explain what is known, what is still experimental, and how any new products would be evaluated before they reach the clinic. Trusted sources such as the CDC, the American Academy of Pediatrics, and children’s hospitals also explain vaccine developments in plain language and update their information as research progresses, which helps families separate real advances from exaggerated headlines.

Looking Ahead

Over the next decade, parents may see new combination vaccines that cover additional diseases, longer-lasting formulations that reduce booster doses, and possibly needle-free options for some vaccines. Each will need to show that it protects as well as current vaccines and is safe before it is recommended. The history of combination vaccines suggests that progress will continue step by step, with each advance reducing the burden of vaccination while maintaining the protection that has made many childhood diseases rare in countries with high vaccination coverage.

In the meantime, staying on the recommended schedule, using combination vaccines where available, and asking questions when something is unclear remain the most effective ways to protect children from serious preventable diseases, and they reflect the best evidence available today.

Vaccines remain one of the most effective tools in medicine, and combination products are part of the continuing effort to make that protection easier to receive. Parents who understand how these vaccines are developed and tested can approach each visit with greater confidence and fewer worries.

Combination Vaccines and Catch-Up Schedules

Combination vaccines are especially useful for children who have fallen behind on their vaccinations, whether because of illness, missed appointments, moving, or disruptions such as the COVID-19 pandemic. The CDC publishes a catch-up schedule that specifies minimum intervals between doses so children can be brought up to date as quickly as safely possible. Using combination products during catch-up visits reduces the number of injections needed at each visit, which can make it easier for families to complete the series. Pediatricians can review a child’s records and recommend which vaccines, including combinations, are appropriate based on the child’s age and previous doses.

Catch-up vaccination is also an opportunity for clinicians to review whether combination products are available and appropriate, since some combinations are licensed only for certain ages or dose numbers. For example, the hexavalent vaccine is licensed for the three-dose infant series and is not used for doses given after a certain age, so older children catching up may receive separate or different combination products instead.

Frequently Asked Questions

Is there a vaccine that gives all childhood immunizations in one shot?

No single shot provides every childhood immunization, but combination vaccines already bundle several into one injection. Examples include MMR (measles, mumps, rubella) and DTaP (diphtheria, tetanus, pertussis), and some vaccines combine even more. These reduce the total number of shots a child needs. Researchers are working on technologies to deliver more protection in fewer injections, but a true all-in-one childhood vaccine does not yet exist.

Are combination vaccines safe for children?

Yes. Combination vaccines are rigorously tested in clinical trials to ensure they are safe and that each component remains effective when given together. They must meet the same high safety standards as individual vaccines before approval, and they are monitored after release. Decades of use show combination vaccines like MMR and DTaP are safe and effective, and they spare children from extra needle sticks.

Does getting several vaccines at once overload a child’s immune system?

No. A child’s immune system is remarkably capable and responds to an enormous number of antigens every day from food, the environment, and ordinary germs. The antigens contained in vaccines, even several given at once, represent a tiny fraction of what the immune system routinely handles. Scientific studies have found no evidence that receiving multiple vaccines simultaneously weakens or overwhelms children’s immunity.

Do modern vaccines contain more ingredients than older ones?

Although children today receive more vaccines than in the past, modern vaccines actually contain far fewer antigens overall. This is because advances in technology allow vaccines to use highly purified, specific components rather than whole organisms. So even with a fuller immunization schedule, the total antigen load from today’s vaccines is lower than it was decades ago, when fewer but cruder vaccines were used.

Why are combination vaccines used instead of separate shots?

Combination vaccines reduce the number of injections and medical visits a child needs, which is less stressful for children and families and improves the likelihood of completing the full vaccination schedule on time. They provide the same protection as separate shots while being more convenient and efficient. Health authorities recommend them because fewer missed doses means better protection against serious preventable diseases across the population.

References

1. Oliver SE, Moore KL. Licensure of a Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus, Haemophilus influenzae Type b Conjugate, and Hepatitis B Vaccine, and Guidance for Use in Infants. MMWR Morbidity and Mortality Weekly Report. 2020;69(5):136–139. PMID 32027629
2. McHugh KJ, Nguyen TD, Linehan AR, et al. Fabrication of fillable microparticles and other complex 3D microstructures. Science. 2017;357(6356):1138–1142. PMID 28912242
3. Offit PA, Quarles J, Gerber MA, et al. Addressing parents’ concerns: do multiple vaccines overwhelm or weaken the infant’s immune system? Pediatrics. 2002;109(1):124–129. PMID 11773551

Last updated: October 6, 2026